Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment

Published:2023-03 Issue:3 Volume:29 Page:353-359
ISSN:1198-743X
Container-title:Clinical Microbiology and Infection
language:en
Short-container-title:Clinical Microbiology and Infection

Author:

Zhang Yangyi,Yu Chenlei,Jiang Yuan,Zheng Xubin,Wang Lili,Li Jing,Shen Xin,Xu Biao

Funder

Shanghai Municipal Health Commission

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference29 articles.

1. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease;Santin;Eur Respir J,2009

2. Nontuberculous mycobacteria—overview;Koh;Microbiol Spectr,2017

3. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases;Griffith;Am J Respir Crit Care Med,2007

4. Genomic insights into the Mycobacterium kansasii complex: an update;Jagielski;Front Microbiol,2019

5. Current updates on mycobacterial taxonomy, 2018 to 2019;Armstrong;J Clin Microbiol,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phylogenomic and genomic analysis reveals unique and shared genetic signatures of Mycobacterium kansasii complex species;Microbial Genomics;2024-07-17

2. Spatial Heterogeneity of Nontuberculous Mycobacterial Pulmonary Disease in Shanghai: Insights from a Ten-Year Population-Based Study;International Journal of Infectious Diseases;2024-06

3. Prevalence of Mycobacterium kansasii in clinical and environmental isolates, a systematic review and meta-analysis;Frontiers in Microbiology;2024-02-19

4. Efficacy of clofazimine-containing regimens for treatment of Mycobacterium avium complex–pulmonary disease in patients unsuitable for standard treatment regimen;International Journal of Antimicrobial Agents;2024-02

5. Risk factors for microbiological persistence after 6 months of treatment for Mycobacterium intracellulare and its impact on the drug-resistance profile;Microbiology Spectrum;2023-10-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3